Download Files:

Fiduxosin

SKU T11286-1 mg Category Small Compound Brand: TargetMol

Price range: 1,120 CAD through 2,880 CAD

For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.

Size

1 mg 5 mg

Clear

Products Details

Product Description

– Fiduxosin is a selective and potent α1-adrenoceptor antagonist with inhibitory effects on α1a-adrenoceptor, α1b-adrenoceptor and α1d-adrenoceptor, with Ki values of 0.160 nM, 24.9 nM and 0.920 nM, respectively. Fiduxosin can be used for the treatment of benign prostatic hyperplasia.

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– T11286

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C30H29N5O4S

References

– Brune ME, et al. Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs. J Pharmacol Exp Ther. 2002 Feb;300(2):487-94.

CAS Number

– 208993-54-8

Molecular Weight

– C30H29N5O4S

Compound Purity

– 0.9973

SMILES

– O=C1C2=C(C=3C(S2)=NC=C(N3)C4=CC=CC=C4)NC(=O)N1CCCCN5C[C@@]6([C@](C5)(COC=7C6=C(OC)C=CC7)[H])[H]

Target

– Others

Pathway

– GPCR/G Protein|||Neuroscience

Product type

– Small Compound

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.